Tumor necrosis factor: Function, release and clearance

Critical Reviews in Immunology

Volumn 16, Issue 1, 1996, Pages 1-11

  Bemelmans, M H A ^a   Van Tits, L J H ^a   Buurman, W A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cytokine; kidney; soluble TNF receptors

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

CLEARANCE; COMPLEX FORMATION; FUTUROLOGY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LIGAND BINDING; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW;

EID: 0029894219     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Coley, W. B., The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases, Am. J. Med. Sci., 5, 487, 1893.
2. Coley, W. B., Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and bacillus prodigiosus, Am. J. Med. Sci., 131, 375, 1906.
3. O'Malley, W. E., Achinstein, B., and Shear, M. J., Action by bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with serratia marcescens polysaccharide, and induced tolerance, J. Natl. Cancer, 29, 1169, 1962.
4. Carswell, E. A., Old, L. J., Green, S., Fiore, N., and Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U.SA., 72, 3666, 1975.
5. Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., and Goeddel, D. V., Humor tumor necrosis factor: precursor structure, expression and homology to lymphotoxin, Nature, 312, 724, 1984.
6. Beutler, B., Mahoney, J., le Trang, N., Pekala, P., and Cerami, A., Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells, J. Exp. Med., 161, 984, 1985.
7. Mahoney, Jr., J. R., Beutler, B. A., le Trang, N., Vine, W., Ikeda, Y., Kawakami, M., and Cerami, A., Lipopolysaccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase in 3T3-L1 cells, J. Immunol., 134, 1673, 1985.
8. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., and Cerami, A., Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature, 316, 552, 1985.
9. Ruddle, N. H. and Waksman, B. H., Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity, J. Exp. Med., 128, 1267, 1968.
10. Granger, G. A. and Williams, T. W., Lymphocyte cytoxicity in vitro: activation and release of a cytotoxic factor, Nature, 218, 1253, 1968.
11. Li, C.-B., Gray, P. W., Lin, P.-F., McGrath, K. M., Ruddle, F. H., and Ruddle, N. H., Cloning and expression of murine lymphotoxin cDNA, J. Immunol., 138, 4496, 1987.
12. Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., Palladino, M, A., and Nedwin, G. E., Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity, Nature, 312, 721, 1984.
13. Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., and Palladino, Jr., M. A., Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors, J. Immunol., 135, 2069, 1985.
14. Browning, J. L., Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R., Pingchang Chow, E., Hession, C., O'Brine-Greco, B., Foley, S. F., and Ware, C. F., Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface, Cell, 72, 847, 1993.
15. Lawton, P., Nelson, J., Tizard, R., and Browning, J. L., Characterization of the mouse lymphotoxin-β gene, J. Immunol., 154, 239, 1995.
16. Fiers, W., Tumor necrosis factor, characterization at the molecular, cellular and in vivo level, FEBS Lett., 285, 199, 1991.
17. Grell, M., Scheurich, P., Meager, A., and Pfizenmaier, K., TR60 and TR80 tumor necosis factor (TNF) receptors can independently mediate cytosis, Lymphokine Res., 12, 143, 1993.
18. Ding, A. H. and Porteu, F., Regulation of tumor necrosis factor receptors on phagocytes, P. Soc. Exp. Biol. Med., 200, 458, 1992.
19. Engelmann, H., Novick, D., and Wallach, D., Two tumor necrosis factor-binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors, J. Biol. Chem., 265, 1531, 1990.
20. Nophar, Y., Kemper, O., Brakebush, C., Engelmann, H., Zwang, R., Aderka, D., Holtman, H., and Wallach, D., Soluble forms of tumor necrosis factor receptors (TNF-Rs): the cDNA for the type 1 TNF-R, cloning using amino and sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor, EMBO J., 9, 3269, 1990.
21. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., Kohr, W. J., and Goeddel, D. V., Molecualr cloning and expression of a receptor for human tumor necrosis factor, Cell, 61, 361, 1990.
22. Heller, R. A., Song, K., Onash, M. A., Fisher, W. H., Chang, D., and Ringold, G. M., Complementary DNA cloning of receptors for tumor necrosis factor and demonstration of a shed form of the receptor, Proc. Natl. Acad. Sci. U.S.A., 87, 6151, 1990.
23. Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., and Loetscher, H., Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A., 87, 3127, 1990.
24. Hohmann, H. P., Remy, R., Brockhaus, M., and van Loon, A. P. G. M., Two different cell types have different major receptors for human tumor necrosis factor (TNFα), J. Biol. Chem., 264, 14927, 1989.
25. Dembic, Z., Loetscher, H., Gubler, U., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., and Lesslauer, W., Two human TNF receptors have similar extracellular, but distinct intracellular, but distinct intracellular, domain sequences. Cytokine, 2, 231, 1990.
26. Armitage, R. J., Tumor necrosis factor receptor superfamily members and their ligands, Curr. Opin. Immunol., 6(3), 407, 1994.
27. Hintzen, R. Q., de Jong, R., Lens, S. M., and van Lier, R. A., CD 27: marker and mediator of T-cell activation? Immunol. Today, 15(7), 307, 1994.
28. Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., and Seldin, M. F., Molecular characterization of murine and human OX 40/OX 40 ligand systems: identification of a human OX 40 ligand as the HLTV-1 regulated protein gp34, EMBO J., 13(17), 3992, 1994.
29. + T cells with homology to tumor necrosis factor, J. Exp. Med., 180(2), 757, 1994.
30. Suda, T., Takahashi, T., Goldstein, P., and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the of the tumor necrosis factor family, Cell, 75(6), 1169, 1993.
31. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell, 76(6), 969, 1994.
32. Loetscher, H., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., Tabuchi, H., and Lesslauer, W., Molecular cloning and expression of the human 55 Kd tumor necrosis factor receptor, Cell, 61, 351, 1990.
33. Stauber, G. B., Aiyer, R. A., and Aggarwal, B. B., Human tumor necrosis-α receptor, J. Biol. Chem., 263, 19088, 1988.
34. Lewis, M., Tartaglia, L. A., Lee, A., Bennet, G. L., Rice, G. C., Wong, G. H. W., Chen, E. Y., and Goeddel, D. V., Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific, Proc. Natl. Acad. Sci., 88, 2830, 1991.
35. Goodwin, R. G., Anderson, D., Jerzy, R., Davis, T., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Smith, C. A., Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor, Mol. Cell. Biol., 11, 3020, 1991.
36. Smith, R. A., Kirstein, M., Fiers, W., and Bagglioni, C., Species specificity of human and murine tumor necrosis factor, J. Biol. Chem., 261, 14871, 1986.
37. Tartaglia, L. A. and Goeddel, D. V., Two TNF receptors, Immunol. Today, 13, 151, 1992.
38. Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A., and Goeddel, D. V., The two different receptors for tumor necrosis factor mediate distinct cellular responses, Proc. Natl. Acad. Sci. U.S.A., 88, 9292, 1991.
39. Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegeman, K., Ohashi, P. S., Krönke, M., and Mak, T. W., Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection, Cell, 73, 457, 1993.
40. Tartaglia, L. A., Rothe, M., Hu, Y.-F., and Goeddel, D. V., Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor, Cell, 73, 213, 1993.
41. Heller, R. A., Song, N., Fan, N., and Chang, D. J., The p70 tumor necrosis factor receptor mediates cytotoxicity, Cell, 70, 47, 1992.
42. Mackay, F., Loetscher, H., Stueber, D., Gehr, G., and Lesslauer, W., Tumor necrosis factor α(TNF-α)- induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55, J. Exp. Med., 177, 1277, 1993.
43. Abe, Y., Gatanaga, M., Osuka, Y., Kimura, S., Burger, R. A., Granger, G. A., and Gatanaga, T., Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecule-1 expression by HL-60 human promyelocytic leukemia cells in vitro, J. Immunol., 150, 5070, 1993.
44. Gehr, G., Gentz, R., Brockhaus, M., Loetscher, H., and Lesslauer, W., Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation, J. Immunol., 149, 911, 1992.
45. Vandenabeele, P., Declercq, W., Vercammen, D., V. D. Craen, M., Grooten, J., Loetscher, H., Brockhaus, M., Lesslauer, W., and Fiers, W., Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T-cell hybridoma, J. Exp. Med., 176, 1015, 1992.
46. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillet, N., and Sheehan, K. C. F., Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-2 deficient mice, Nature, 372, 560, 1994.
47. Leeuwenberg, J. F. M., van Tits, L. J. H., Jeunhomme, T. M. M. A., and Buurman, W. A., Evidence for exclusive role in signaling of tumor necrosis factor P55 receptor and a potentiating function of P75 on human endothelial cells, Cytokine, in press.
48. Olsson, I., Lantz, M., Nilsson, E., Peetre, C., Thyssell, H., Grubb, A., and Adolf, G., Isolation and characterization of a tumor necrosis factor binding protein from urine, Eur. J. Haematol., 42, 270, 1989.
49. Seckinger, P., Isaaz, S., and Dayer, J. M., A human inhibitor of tumor necrosis factor-α, J. Exp. Med., 167, 1511, 1988.
50. Peetre, C., Thysell, H., Grubb, A., and Olsson, I., A tumor necrosis factor binding protein is present in human biological fluids, Eur. J. Haematol., 41, 414, 1988.
51. Lantz, M., Gullberg, U., Nilsson, E., and Olsson, I., Characterization in vitro of a human tumor necrosis factor-binding protein, J. Clin. Invst., 86, 1396, 1990.
52. Novick, D., Engelmann, H., and Wallach, D., Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography, J. Chromatogr., 510, 331, 1990.
53. Porteu, F. and Natan, C., Shedding of tumor necrosis factor by activated human neutrophils, J. Exp. Med., 172, 599, 1990.
54. Scannell, G., Waxman, K., Kaml, G. J., Ioli, G., Gatanaga, T., Yamamoto, R., and Granger, G. A., Hypoxia induces a human macrophage cell line to release tumor necrosis factor-α and its soluble receptors in vitro, J. Surg. Res., 54, 28, 1993.
55. Spinas, G. A., Keller, U., and Brockhaus, M., Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxemia, J. Clin. Invest., 90, 533, 1992.
56. Van Zee, K. J., Kohmo, T., Fischer, E., Rock, C. S., Moldawer, L. L., and Lowry, S. F., Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factorα in vivo, Proc. Natl. Acad. Sci. U.S.A., 89, 4845, 1992.
57. Tan, L. R., Waxman, K., Scanell, G., Loli, G., and Granger, G. A., Trauma causes early release of soluble receptors for tumor necrosis factor, J. Trauma, 34, 634, 1993.
58. Shapiro, L., Clark, B. D., Orencole, S. F., Poutsiaka, D. D., Granowotz, E. V., and Dinarello, C. A., Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans, J. Inf. Dis., 167, 1344, 1993.
59. Bemelmans, M. H. A., Abramowicz, D., Gouma, D. J., Goldman, M., and Buurman, W. A., In vivo T-cell activation by anti-CD3 mAb induces soluble TNF receptor release in mice: effects of pentoxifylline, methylprednisolone, anti-TNF and anti-γ antibodies, J. Immunol., 153, 499, 1994.
60. Aderka, D., Engelmann, H., Maor, Y., Brakebush, C., and Wallach, D., Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, J. Exp. Med., 175, 323, 1992.
61. Leeuwenberg, J. F. M., Dentener, M. A., and Buurman, W. A., Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS-binding protein, and bactericidal/permeability increasing protein, J. Immunol., 152, 5070, 1994.
62. Bertini, R., Delgado, R., Faggioni, R., Gascon, M., Ythier, A., and Ghezzi, P., Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock, Eur. Cytokine Netw., 4, 39, 1993.
63. Lesslauer, W., Tabuchi, H., Gentz, M., Brockhaus, M., Schlaegger, E. J., Grau, G., Piguet, P. F., Pontaire, P., Vassali, P., and Loetscher, H., Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality, Eur. J. Immunol., 21, 2883, 1991.
64. Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamov, S. M., Figari, I. S., Pennica, D., Goeddel, D. V., Palladino, M. A., and Smith, D, H., Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin, Proc. Natl. Acad. Sci. U.S.A., 88, 10535, 1991.
65. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H., and Widmer, M. B., Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists, J. Immunol., 151, 1548, 1993.
66. Brockhaus, M., Bar-Khayim, Y., Gruwicz, S., Frensdorff, A., and Haran, N., Plasma tumor necrosis factor soluble receptore in chronic renal failure, Kidney Int., 42, 663, 1992.
67. Froon, A. H. M., Bemelmans, M. H. A., Greve, J. W., van der Linden, C. J., and Buurman, W. A., Increased plasma levels of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine, Crit. Care, 1994.
68. Von Allmen, D., Hasselgren, P., Higashiguchi, T., Frederick, J., Zamir, O., and Fisher, J. E., In creased intestinal protein sythesis during sepsis and following the administration of tumor necrosis factor-α interleuken-lα, Biochem. J., 286, 585, 1992.
69. Beutler, B. and Cerami, A., Cachectin: more than a tumor necrosis factor, New Engl. J. Med, 316, 379, 1987.
70. Manogue, K. R., van Deventer, S. J. H., and Cerami, A., Tumor necrosis factor or cachectin, in: The Cytokine Handbook, Thompson, A., Ed., Academic Press, London, 1992.
71. Lienard, D., Lejeune, F., Delmotte, J., Renard, N., and Ewalenko, P., High-dose recombinant tumor necrosis factor-α in combination with interferon-γ and malphalan in isolation perfusion of the limbs for melanoma and sarcoma, J. Clin. Onc., 10, 52, 1992.
72. Molloy, R. G., Mannick, J. A., and Rodrick, M. L., Cytokines, sepsis and immunomodulation, Br. J. Surg., 80, 289, 1993.
73. Waage, A., Halstensen, A., and Espevik, T., Association between tumor necrosis factor in serum and fatal outcome in patients with meninggococcal disease, Lancet, 355, 1987.
74. Millar, A. B., Singer, M., Meager, A., Foley, N. M., Johnson, N. Mcl., and Rook, G. A. W., Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome, Lancet, 712, 1989.
75. Tracey, K. J. and Cerami, A., Cachectin/tumor necrosis factor and other cytokines in infectious disease, Curr. Opin. Immunol., 1, 454, 1989.
76. Van Ostade, X., Vandenabeele, P., Everaerdt, B., Loetscher, H., Gentz, R., Brockhaus, M., Lesslauer, W., Tavernier, J., Broukaert, P., and Fiers, W., Human TNF mutants with selective activity on the p55 receptor, Nature, 361, 266, 1993.
77. Murch, S. H., Lamkin, V. A., Savage, M. O., Walker-Smith, J. A., and MacDonald, T. T., Serum concentrations of tumor necrosis factor-α in childhood chronic inflammatory bowel disease, Gut, 32, 913, 1991.
78. De Suva, D. G. H., Mendis, L. N., Sheron, N., Alexander, G. J. M., Candy, D. C. A., Chart, H., and Rowe, B., TNFα in stool as marker of intestinal inflammation, Lancet, 340, 372, 1992.
79. Braegger, C. P., Nicholls, S., Murch, S. H., Stephens, S., and MacDonald, T. T., Tumor necrosis factor-α in stool as a marker of intestinal inflammation, Lancet, 339, 89, 1992.
80. Lanfranchi, G. A. and Tragnone, A., Serum and faecal tumor necrosis factor-α as marker of intestinal inflammation, Lancet, 339, 1053, 1992.
81. Maeda, M., Watanabe, N., Neda, H., Yamauchi, N., Okamoto, T., Sasaki, H., Tsuji, Y., Akiyama, S., Tsuji, Y., and Niitsu, Y., Serum tumor necrosis factor activity in inflammatory bowel disease, Immunopharm. Immunot., 14, 451, 1992.
82. Mahida, Y. R., Scott, E., Kurlak, L., Gallagher, A., and Hawkey, C. J., Interleukin-1β, tumor necrosis factor-α and interleukin-6 synthesis by circulating mononuclear cells isolated from patients with active ulcerative colitis and Crohn's disease, Eur. J. Gastroenterology and Hepatol., 4, 501, 1992.
83. Andus, T., Gross, V., Cäsar, I., Krumm, D., Hosp, J., David, M., and Schölmerich, J., Activation of monocytes during inflammatory bowel disease, Pathohiology, 59, 166, 1991.
84. Schreiber, S., MacDermott, R. P., Raedler, A., Pinnau, R., Bertovich, M. J., and Nash, G. S., Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease, Gastroenterology, 101, 1020, 1991.
85. Silva, A. T., Bayston, K. F., and Cohen, J., Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock, J. Inf. Dis., 162, 421, 1990.
86. Beutler, B., Milsark, I. W., and Cerami, A. C., Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin, Science, 229, 869, 1985.
87. McGonnen, M., Immunex's soluble receptors proving their anti-inflammatory point in the clinic, Biotechnology News, 13, 1, 1993.
88. Abraham, E., Wunderink, R., Silverman, H., Nasraway, S., Levy, H., Bone, R., Wenzel, R. P., Balk, R., Allred, R., Pennington, J. E., and Wherry, J. C., Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome, J.A.M.A., 273, 934, 1995.
89. Saravolatz, L. D., Wherry, J. C., and Spooner, C., Clinical safety, tolerability and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-α, J. Infect. Dis., 169, 214, 1994.
90. Echtenacher, B., Falk, W., Männel, D. N., and Krammer, P. H., Requirement of endogeneous tumor necrosis factor/cachectin for recovery from experimental peritonitis, J. Immunol., 145, 3762, 1990.
91. Allendoerfer, R., Magee, D. M., Smith, J. G., Bonewald, L., and Graybill, J. R., Induction of tumor necrosis factor-α in murine Candida albicans infection, J. Inf. Dis., 167, 1168, 1993.
92. Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., and Leeb, B., Randomised double blind comparison of chimeric monoclonal antibody to tumor necrosis factor-α (cA2) versus placebo in rheumatoid arthritis, Lancet, 344(8930), 1105, 1994.
93. Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., and Feldmann, M., Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis, J. Clin. Invest., 94(2), 749, 1994.
94. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Katsikis, P., and Brennan, F, M., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α, Arthritis Rheum., 36(12), 1681, 1993.
95. Cope, A. P., Aderka, D., Doherty, M., Engelmann, H., Gibbons, D., Jones, A. C., Brennan, F. M., Maini, R. N., Wallach, D., and Feldmann, M., Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases, Arthritis Rheum., 35, 1160, 1992.
96. Katsikis, P. D., Chu, C. Q., Brennen, F. M., Maini, R. N., and Feldmann, M., Immunoregulatory role of interleukin-10 in rheumatoid arthritis, J. Exp. Med., 179(5), 1517, 1994.
97. Murch, S. H. and Walker-Smith, J. A., Medical management of chronic inflammatory bowel disease, Baillieres Clin. GastroenteroL, 8(1), 133, 1994.
98. Engelberts, I., Moller, A., Schoen, G. J. M., van der Linden, C. J., and Buurman, W. A., Evaluation of measurement of human TNF in plasma by ELISA, Lymphokine Res., 10, 133, 1991.
99. Engelberts, I., Stevens, S., Francot, G. J. M., van der Linden, C. J., and Buurman, W. A., Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids, Lancet, 338, 515, 1991.
100. Alegre, M., Vandenabeele, P., Flamand, V., Moser, M., Leo, O., Abramowicz, D., Urbain, J., Fiers, W., and Goldman, M., Hypothermia and hypglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor, Eur. J. Immunol., 20, 707, 1990.
101. Debets, J. M. H., van der Linden, C. J., Dieteren, I. E. M., Leeuwenberg, J. F. M., and Buurman, W. A., Fc-receptor cross-linking induces secretion of tumor necrosis factor by monocytes, J. Immunol., 141, 1197, 1988.
102. Debets, J. M. H., van der Linden, C. J., Spronken, I. E. M., and Buurman, W. A., T-cell mediated secretion of tumor necrosis factor by monocytes, Scand. J. Immunol., 27, 601, 1988.
103. Leeuwenberg, J. F. M., Jeunhomme, T. M. M. A., and Buurman, W. A., Slow release of soluble TNF receptors by monocytes in vitro, J. Immunol., 152, 4036, 1994.
104. Coletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Stricter, R. M., and Campbell, Jr., D. A., Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat, J. Clin. Invest., 85, 1936, 1990.
105. Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Wooley, K., Processing of tumor necrosis factor-α precursor by metalloproteinases, Nature, 370, 555, 1994.
106. McGeeham, G. M., Becherer, J. D., Bast, R. C., Boyer, C. M., Champion, B., Conolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwanski, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J., and Ways, J. P., Regulation of tumor necrosis factor-α processing by a metalloproteinase inhibitor, Nature, 370, 558, 1994.
107. Macchia, D., Almerigogna, F., Parronchi, P., Ravina, A., Maggi, E., and Romanani, S., Membrane tumor necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells, Nature, 363, 464, 1993.
108. Kriegler, M., Perez, C., DeFay, K., Albert, I., and Lu, S. D., A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 53, 45, 1988.
109. Jones, E. Y., Stuart, D. I., and Walker, N. P. C. B., Structure of tumor necrosis factor, Nature, 338, 225, 1989.
110. Eck, M. J., Beutler, B., Kuo, G., Merry weather, J. P., and Sprang, S. R., Crystallization of trimeric recombinant human tumor necrosis factor (cachectin), J. Biol. Chem., 263, 12816, 1988.
111. Pessina, G. P., Pacini, A., Bocci, V., Maioli, E., and Naldini, A., Studies on tumor Necrosis factor (TNF): II. Metabolic fate and distribution of human recombinant TNF, Lymphokine Res., 6, 35, 1987.
112. Beutler, B. A., Milsark, I. A., and Cerami, A., Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo, J. Immunol., 135, 3972, 1985.
113. Bemelmans, M. H. A., Gouma, D. J., and Buurman, W. A., Influence of nephrectomy on tumor necrosis factor clearance in a murine model, J. Immunol., 150, 2007, 1993.
114. Bemelmans, M. H. A., Gouma, D. J., and Buurman, W. A., Tissue distribution and clearance of soluble murine TNF receptors in mice, Cytokine, 6, 608, 1994.
115. Bemelmans, M. H. A., Gouma, D. J., and Buurman, W. A., LPS-induced sTNF-receptor release in vivo in a murine model, Investigation of the role of tumor necrosis factor, IL-1, Leukemia-inhibiting factor, and INF-γ, J. Immunol., 151, 5554, 1993.
116. Alegre, M. L., Vandenabeele, P., Depierreux, M., Floquin, S., Deschodt-Lanckman, M., Flamand, V., Moser, M., Leo, O., Urbain, J., Fiers, W., and Goldman, M., Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone, J. Immunol., 146, 1184, 1991.
117. Chatenoud, L., Legendre, C., Ferran, C., Bach, J. F., and Kreis, H., Corticostcroid inhibition of the OKT3-induced cytokine related syndrome; dosage and kinetics prerequisites, Transplantation, 51, 334, 1991.
118. Ferran, C., Dy, M., Merite, S., Sheehan, K., Schreiber, R., Leboulenger, F., Landais, P., Bluestone, J., Bach, J. F., and Chatenoud, L., Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids, Transplantation, 50, 642, 1990.